Sign Up Today and Learn More About Ultromics Stock
Invest in or calculate the value of your shares in Ultromics or other pre-IPO companies through EquityZen's platform.
Ultromics Stock
Ultromics clinicians and engineers working together to set new standards for world-class cardiovascular diagnostic tools.
About Ultromics Stock
Founded
2017
Industries
Software, Artificial Intelligence, Data and Analytics
Ultromics Press Mentions
Stay in the know about the latest news on Ultromics
Advancing cardiovascular health – SignaCor Therapeutics lands €288k investment as pat of €1.1 million Seed round
eu-startups • Mar 10, 2026
Biotech investors want to see a clear strategy
businessweekly • Jan 31, 2026
AHA Invests in AI that Tackles Cardiology’s Gender Bias Problem
medcitynews • Dec 24, 2025
Go Red for Women Venture Fund invests in Ultromics
bioworld • Dec 19, 2025
Ultromics Secures Strategic Investment from the American Heart Association's Go Red for Women Venture Fund™
prnewswire • Dec 17, 2025
Ultromics Management
Leadership team at Ultromics
CEO
Ross Upton
CMO
Paul Leeson
Join now and verify your accreditation status to gain access to:
- Ultromics Current Valuation
- Ultromics Stock Price
- Ultromics Management
- Available deals in Ultromics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Ultromics Cap Table and Funding History by Share Class and Liquidity Preferences
- Ultromics Revenue and Financials
- Ultromics Highlights
- Ultromics Business Model
- Ultromics Risk Factors
- Ultromics Research Report from SACRA Research
Trading Ultromics Stock
How to invest in Ultromics stock?
Accredited investors can buy pre-IPO stock in companies like Ultromics through EquityZen funds. These investments are made available by existing Ultromics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Ultromics stock?
Shareholders can sell their Ultromics stock through EquityZen's private company marketplace. EquityZen's network includes over 440K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 52K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."